Replication and refinement of the role of rs548181 in schizophrenia: Results from a family based study

Authors

  • Eske M. Derks,

    Corresponding author
    1. Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    2. Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    • Department of Psychiatry, Academic Medical Center, University of Amsterdam, Meibergdreef 5, 1105 AZ, Amsterdam, The Netherlands.
    Search for more papers by this author
  • Roel A. Ophoff,

    1. Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands
    2. UCLA Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, California
    Search for more papers by this author
  • Genetic Risk Outcome of Psychosis (GROUP)

    Search for more papers by this author
    • GROUP investigators include: René S. Kahn(1), Don Linszen(2), Jim van Os(3), Durk Wiersma(4), Richard Bruggeman(4), Wiepke Cahn(1), Lieuwe de Haan(2), Lydia Krabbendam(3), and Inez Myin-Germeys(3); 1. Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, TheNetherlands; 2. Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 3 Mental Health Research and Teaching Network, Maastricht University Medical Center, South Limburg, Maastricht, The Netherlands; 4. Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.


  • How to Cite this Article: Derks EM, Ophof RA, Genetic Risk and Outcome of Psychosis (GROUP). 2012. Replication and Refinement of the Role of rs548181 in Schizophrenia: Results From a Family Based Study. Am J Med Genet Part B 162B:75–77.

No abstract is available for this article.

Ancillary